Physician profile
Charles Sharp
NPI 1215903810
$2,676.06
in general payments reported to CMS, 2019-2025
38 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $333 · 2021: $387 · 2022: $332 · 2023: $479 · 2024: $299 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,050.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $562.21 | 2019-2025 | Liletta, Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $475.73 | 2019-2025 | Veozah, Myrbetriq |
| Amgen INC. | $218.26 | 2019-2025 | Evenity |
| Shield Therapeutics INC | $131.88 | 2022-2025 | Accrufer |
| Mylan Pharmaceuticals INC. | $103.06 | 2019-2022 | |
| Hologic Sales and Service, LLC | $100.41 | 2020-2025 | Aptima |
| Glaxosmithkline, LLC. | $96.33 | 2023-2024 | Shingrix, Arexvy, Boostrix |
| Scynexis, INC. | $85.60 | 2022 | |
| Therapeuticsmd, INC. | $80.02 | 2019-2022 | |
| Ethicon US, LLC | $73.04 | 2019-2021 | |
| Coopersurgical, INC. | $67.53 | 2020-2021 | |
| Novo Nordisk INC | $60.99 | 2019-2025 | Wegovy |
| Exeltis, USA INC. | $53.67 | 2020-2023 | Slynd |
| Lilly USA, LLC | $52.62 | 2020-2025 | Zepbound |
| Minerva Surgical, INC | $41.22 | 2023-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $37.26 | 2023 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $37.21 | 2020-2025 | |
| Exact Sciences Corporation | $32.60 | 2023-2024 | Cologuard Collection Kit |
| Amag Pharmaceuticals, INC. | $30.30 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $29.06 | 2023 | Seglentis, Livalo |
| Mayne Pharma Commercial LLC | $28.55 | 2022-2025 | |
| Duchesnay USA Incorporated | $28.20 | 2019-2020 | |
| Organon LLC | $27.70 | 2022-2023 | Jada System |
| Becton, Dickinson and Company | $26.97 | 2022-2023 | Bd Onclarity |
| Virtus Pharmaceuticals LLC | $24.60 | 2021 | |
| Roche Diagnostics Corporation | $21.54 | 2019 | |
| Meditrina | $21.18 | 2025 | |
| Daiichi Sankyo INC. | $20.67 | 2019 | |
| Lundbeck LLC | $20.40 | 2021 | |
| Convatec INC. | $19.01 | 2019 | |
| Sage Therapeutics, LLC | $16.89 | 2024 | |
| Lsi Solutions INC | $14.27 | 2021 | |
| Coloplast Corp | $12.56 | 2021 | |
| Vertical Pharmaceuticals, LLC | $12.52 | 2020 | |
| Lupin INC. | $12.00 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Sharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.